News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Kite Pharma
NEWS
JOBS
IN THE PRESS
NEWS
Deals
How Gilead and Kite Pharma’s Flirtation Became the Real Thing
September 6, 2017
·
3 min read
Deals
Can Gilead Squeeze $12 Billion From Kite Pharma?
August 30, 2017
·
1 min read
Deals
Gilead And Kite Pharma. A $12 Billion Deal. One More Pricey Drug.
August 29, 2017
·
1 min read
Policy
Kite Pharma Gets A Pass From FDA On Axi-cel Panel Review
August 8, 2017
·
1 min read
Drug Development
Kite Pharma Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy
July 20, 2017
·
3 min read
Policy
Waiting Lists are Already Forming for Novartis AG and Kite Pharma’s Not-Yet Approved CAR-T Drugs
July 7, 2017
·
3 min read
Drug Development
A Look at the Deaths That Plagued Juno and Kite Pharma’s CAR-T Trials
June 27, 2017
·
3 min read
Deals
Tiny Bob Langer-Backed Kite Pharma Files For $86 Million IPO
June 27, 2017
·
1 min read
Drug Development
Kite Pharma Stock Plunges After Report of Patient Death in CAR-T Clinical Trial
May 8, 2017
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
February 22, 2018
·
8 min read
Deals
Gilead Completes Tender Offer For All Outstanding Shares Of Kite Pharma
October 3, 2017
·
5 min read
Deals
Gilead Completes Acquisition Of Kite Pharma
October 3, 2017
·
5 min read
Deals
Gilead And Kite Pharma Announce Expiration Of Hart-Scott-Rodino Waiting Period
September 26, 2017
·
5 min read
Business
CryoPort Selected To Support The Potential Commercial Launch Of Kite Pharma’s CAR-T Therapy Axicabtagene Ciloleucel
September 5, 2017
·
4 min read
Drug Development
Kite Pharma Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3
August 17, 2017
·
4 min read
Business
Kite Pharma Reports Second Quarter 2017 Financial Results
August 8, 2017
·
4 min read
Policy
Kite Pharma Files Key FDA Filing for KITE-585
August 8, 2017
·
4 min read
Biotech Beach
Kite Pharma Announces Initiation Of Axicabtagene Ciloleucel CAR-T Clinical Program In The European Union
August 7, 2017
·
4 min read
Biotech Beach
Kite Pharma Announces Landmark Study Of Refractory Aggressive Non-Hodgkin Lymphoma (SCHOLAR-1) Outcomes Published In The Journal BLOOD
August 4, 2017
·
4 min read